Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04314843
Title Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma (ZUMA-19)
Acronym ZUMA-19
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Kite, A Gilead Company
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94305 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Northwestern University Evanston Illinois 60208 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Columbia University Medical Center, New York-Presbyterian Hospital New York New York 10032 United States Details
Levine Cancer Center Charlotte North Carolina 28204 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field